Mycobacterium leprae and leprosy: A compendium

Microbiology and Immunology

Volumn 45, Issue 11, 2001, Pages 729-736

  Sasaki, Shin ^a   Takeshita, Fumihiko ^a   Okuda, Kenji ^b   Ishii, Norihisa ^a  

^a NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

^b YOKOHAMA CITY UNIVERSITY   (Japan)

Author keywords

Leprosy; Mycobacterium leprae; Pseudogene; Schwann cells; Th1 Th2 dichotomy

Indexed keywords

CLOFAZIMINE; DYSTROGLYCAN; LAMININ; LEPROSTATIC AGENT; MINOCYCLINE; OFLOXACIN; RIFAMPICIN;

ANTIBIOTIC THERAPY; BACTERIAL GENE; HUMAN; IMMUNE RESPONSE; JAPAN; LEPROSY; MYCOBACTERIUM LEPRAE; MYCOBACTERIUM TUBERCULOSIS; NEUROPATHY; PSEUDOGENE; SCHWANN CELL; SHORT SURVEY;

ANIMALS; HUMANS; LEPROSY; LEPROSY, LEPROMATOUS; LEPROSY, TUBERCULOID; MYCOBACTERIUM LEPRAE; PERIPHERAL NERVOUS SYSTEM; PREVALENCE; PSEUDOGENES; ZOONOSES;

ACTINOBACTERIA (CLASS); BACTERIA (MICROORGANISMS); MYCOBACTERIUM LEPRAE; MYCOBACTERIUM TUBERCULOSIS; UNCULTURED ACTINOMYCETE;

EID: 0035192997     PISSN: 03855600     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1348-0421.2001.tb01308.x     Document Type: Article

References (39)

1. Recognition of a lipid antigen by CD1-restricted αβ+ T cells
2. A case-control study of the effectiveness of BCG vaccine for preventing leprosy in Yangon
3. A simple dipstick assay for the detection of antibodies to phenolic glycolipid-I of Mycobacterium leprae
4. IgM anti-phenolic glycolipid-I antibody measurements from skin-smear sites: Correlation with venous antibody levels and the bacterial index
5. T cell effector subsets: Extending the Th1/Th2 paradigm
6. Detection of phenolic glycolipid I of Mycobacterium leprae in sera from leprosy patients before and after start of multidrug therapy
7. Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence
8. Massive gene decay in the leprosy bacillus
9. Leprosy transmission and mucosal immunity: Towards eradication?
10. Sustainability of leprosy control services in low endemic situations
11. Approaches to studying the transmission of Mycobacterium leprae
12. Survey of newly diagnosed leprosy patients in native and foreign residents of Japan
13. Leprosy
14. Randomised controlled trial of single BCG, repeated BCG, or combined BCG and killed Mycobacterium leprae vaccine for prevention of leprosy and tuberculosis in Malawi
15. Tumour necrosis factor-α (TNF-α) synthesis is associated with the skin and peripheral nerve pathology of leprosy reversal reactions
16. Attempts to establish the armadillo (Dasypus novemcinctus Linn.) as a model for the study of leprosy. I. Report of lepromatoid leprosy in an experimentally infected armadillo
17. Nonhuman sources of leprosy
18. Th1-Th2 paradigm: Insights from leprosy
19. The CD1-restricted T-cell response to mycobacteria
20. T-cell release of granulysin contributes to host defense in leprosy
21. Transmission and protection in leprosy: Indications of the role of mucosal immunity
22. How does Mycobacterium leprae target the peripheral nervous system?
23. Neural targeting of Mycobacterium leprae mediated by the G domain of the laminin-α2 chain
24. Role of α-dystroglycan as a Schwann cell receptor for Mycobacterium leprae
25. The mycobacteria: An introduction to nomenclature and pathogenesis
26. Classification of leprosy according to immunity. A five-group system
27. Mycobacterium leprae and Mycobacterium lepraemurium infections in domestic and wild animals
28. Cortisol metabolism, cortisol sensitivity and the pathogenesis of leprosy reactions
29. Differing lymphokine profiles of functional subsets of human CD4 and CD8 T cell clones
30. The experimental disease that follows the injection of human leprosy bacilli into footpads of mice
31. A 21-kDa surface protein of Mycobacterium leprae binds peripheral nerve laminin-2 and mediates Schwann cell invasion
32. Novel mechanisms in the immunopathogenesis of leprosy nerve damage: The role of Schwann cells, T cells and Mycobacterium leprae
33. The epidemiology of Mycobacterium leprae: Recent insight
34. Mycobacterium lepraemillennium resistant! Leprosy control on the threshold of a new era
35. Leprosy - Global situation
36. Defining protective responses to pathogens: Cytokine profiles in leprosy lesions